The covid-19 vaccine, developed by the University of Oxford, is reported to be safe and produced much immune response in clinical trials, according to a data published on Monday, July 20.
The vaccine named AZD1222 did not show any serious side effects and did not prompt any serious side effects and evoked antibody and T-cell immune responses, said the results that were published in the Lancet Medical Journal. AstraZeneca and scientists at Britain’s University of Oxford developed the vaccine.
The trial was conducted in 1,077 people. In trial, it was found these people developed antibodies and T-cells that are known to fight the deadly virus. Lead author Andrew Pollard of the University of Oxford said that there was much hope in the vaccine. However, he maintained that more research was needed to confirm the effectiveness of the vaccine.
The Oxford University began the trial in April. The researchers said that the vaccine produced a dual immune response in people aged 18 to 55. The study showed that the vaccine induces strong antibody and T-cell immune responses for 56 days.
The vaccine is made from a genetically engineered virus that causes common cold in chimpanzees. The vaccine from the Oxford University is not the first one that has reached this stage. Moderna was the first to publish a positive test result of their vaccine. BioNtech and Pfizer have also had positive results using their RNA vaccine.
